Page last updated: 2024-11-03

procainamide and Carcinoma, Small Cell

procainamide has been researched along with Carcinoma, Small Cell in 1 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giannone, L1
Kugler, JW1
Krantz, SB1

Other Studies

1 other study available for procainamide and Carcinoma, Small Cell

ArticleYear
Pure red cell aplasia associated with administration of sustained-release procainamide.
    Archives of internal medicine, 1987, Volume: 147, Issue:6

    Topics: Aged; Anemia, Aplastic; Carcinoma, Small Cell; Delayed-Action Preparations; Drug Therapy, Combinatio

1987